Clinical trials
Medulloblastoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 5 |
| Beijing Tiantan Hospital | 2 |
| Beijing Sanbo Brain Hospital | 1 |
| Fudan University | 1 |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
| Jiujiang University Affiliated Hospital | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| Sun Yat-sen University | 1 |
| West China Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medulloblastoma | 15 |
| Glioblastoma | 3 |
| Glioma | 3 |
| Neuroblastoma | 3 |
| Wilms Tumor | 3 |
| Brain Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Central Nervous System Neoplasms | 2 |
| Colonic Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.